IL318765A - Predicting response to il-6 antagonists - Google Patents
Predicting response to il-6 antagonistsInfo
- Publication number
- IL318765A IL318765A IL318765A IL31876525A IL318765A IL 318765 A IL318765 A IL 318765A IL 318765 A IL318765 A IL 318765A IL 31876525 A IL31876525 A IL 31876525A IL 318765 A IL318765 A IL 318765A
- Authority
- IL
- Israel
- Prior art keywords
- antagonists
- predicting response
- predicting
- response
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
- C07K16/248—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22203165 | 2022-10-24 | ||
| PCT/EP2023/079391 WO2024088921A1 (en) | 2022-10-24 | 2023-10-23 | Predicting response to il-6 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL318765A true IL318765A (en) | 2025-04-01 |
Family
ID=83995003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL318765A IL318765A (en) | 2022-10-24 | 2023-10-23 | Predicting response to il-6 antagonists |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250333495A1 (en) |
| EP (1) | EP4608861A1 (en) |
| JP (1) | JP2025535355A (en) |
| KR (1) | KR20250093319A (en) |
| CN (1) | CN120112551A (en) |
| AU (1) | AU2023369998A1 (en) |
| CA (1) | CA3264497A1 (en) |
| IL (1) | IL318765A (en) |
| MX (1) | MX2025004613A (en) |
| TW (1) | TW202426494A (en) |
| WO (1) | WO2024088921A1 (en) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69233528T2 (en) | 1991-11-25 | 2006-03-16 | Enzon, Inc. | Process for the preparation of multivalent antigen-binding proteins |
| ATE199392T1 (en) | 1992-12-04 | 2001-03-15 | Medical Res Council | MULTIVALENT AND MULTI-SPECIFIC BINDING PROTEINS, THEIR PRODUCTION AND USE |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| EP0979281B1 (en) | 1997-05-02 | 2005-07-20 | Genentech, Inc. | A method for making multispecific antibodies having heteromultimeric and common components |
| JP3614866B2 (en) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ,インコーポレイティド | Artificial antibody polypeptide |
| DE69941267D1 (en) | 1998-12-10 | 2009-09-24 | Bristol Myers Squibb Co | PROTEIN EQUIPMENT FOR ANTIBODY-NACHHAMMER AND OTHER BINDING PROTEINS |
| JP4369662B2 (en) | 2001-04-26 | 2009-11-25 | アビディア インコーポレイテッド | Combinatorial library of monomer domains |
| US20030157561A1 (en) | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
| WO2006028936A2 (en) | 2004-09-02 | 2006-03-16 | Genentech, Inc. | Heteromultimeric molecules |
| KR102149206B1 (en) | 2012-11-08 | 2020-08-31 | 세센 바이오, 아이엔씨. | Il-6 antagonists and uses thereof |
| SI3215530T1 (en) * | 2014-11-07 | 2020-02-28 | Sesen Bio, Inc. | Enhanced IL-6 antibodies |
| WO2016089886A2 (en) * | 2014-12-02 | 2016-06-09 | Regeneron Pharmaceuticals, Inc. | Methods for treating dry eye disease by administering an il-6r antagonist |
| BR112018008900A8 (en) * | 2015-11-03 | 2019-02-26 | Regeneron Pharma | compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of use thereof |
| WO2021226404A1 (en) * | 2020-05-08 | 2021-11-11 | Kodiak Sciences Inc. | Use of il-6 antibodies and vegf traps, and fusion constructs and conjugates thereof |
-
2023
- 2023-10-23 KR KR1020257013322A patent/KR20250093319A/en active Pending
- 2023-10-23 CA CA3264497A patent/CA3264497A1/en active Pending
- 2023-10-23 JP JP2025522518A patent/JP2025535355A/en active Pending
- 2023-10-23 TW TW112140392A patent/TW202426494A/en unknown
- 2023-10-23 CN CN202380074250.7A patent/CN120112551A/en active Pending
- 2023-10-23 IL IL318765A patent/IL318765A/en unknown
- 2023-10-23 EP EP23794306.3A patent/EP4608861A1/en active Pending
- 2023-10-23 WO PCT/EP2023/079391 patent/WO2024088921A1/en not_active Ceased
- 2023-10-23 AU AU2023369998A patent/AU2023369998A1/en active Pending
-
2025
- 2025-04-21 MX MX2025004613A patent/MX2025004613A/en unknown
- 2025-04-21 US US19/184,178 patent/US20250333495A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250333495A1 (en) | 2025-10-30 |
| KR20250093319A (en) | 2025-06-24 |
| WO2024088921A1 (en) | 2024-05-02 |
| TW202426494A (en) | 2024-07-01 |
| JP2025535355A (en) | 2025-10-24 |
| CA3264497A1 (en) | 2024-05-02 |
| AU2023369998A1 (en) | 2025-01-23 |
| MX2025004613A (en) | 2025-06-02 |
| EP4608861A1 (en) | 2025-09-03 |
| CN120112551A (en) | 2025-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4420617C0 (en) | COMPRESSABLE NON-FIBERY ADDITIVES | |
| EP3776283A4 (en) | DIGITAL CONSTRUCTION TOOLS FOR BUILDING CONSTRUCTION | |
| EP3926100A4 (en) | UNDERWATER CONCRETE BLOCK STRUCTURE CONSTRUCTION METHOD | |
| EP4073075A4 (en) | SSTR5 ANTAGONISTS | |
| IL285246A (en) | Substitute bicyclic compounds as modular farnesoid x receptors | |
| EP4067506A4 (en) | BIOMARKER FOR PREDICTING THERAPEUTIC RESPONSIVENESS TO A THERAPEUTIC AGENT OF IMMUNE CELLS | |
| ZA202007980B (en) | P2x3 receptor antagonists | |
| GB202019622D0 (en) | Antagonist compounds | |
| IL292639A (en) | Heterocyclic nmda antagonist | |
| EP4511368A4 (en) | CCR4 ANTAGONISTS | |
| EP4006033A4 (en) | ADENOSINE RECEPTOR ANTAGONIST | |
| EP4257765A4 (en) | OCTAHEDRAL RETICULATED STEREO MODULE FOR BUILDING CONSTRUCTION | |
| HUE058848T2 (en) | Inflammatory biomarkers for predicting responsiveness to FGF-18 compound | |
| GB2607218B (en) | Sound-insulating structure for building | |
| EP4452969A4 (en) | PIPERAZINE-INDAZOLE-GLUCOCORTICOID RECEPTOR ANTAGONISTS | |
| EP3798588C0 (en) | MONOLITHIC WEIGHING BLOCK | |
| IL291502A (en) | Agonist of tacr2 | |
| PL4041388T3 (en) | PROSTAGLANDIN EP4 RECEPTOR ANTAGONIST COMPOUNDS | |
| EP3924556C0 (en) | MONOLITHIC NETWORK STRUCTURE FOR GEO-GRIDS | |
| IL285557A (en) | Resistant compounds used are similar to farnesoid x receptor antagonists | |
| IL290024A (en) | Bicyclic cx3cr1 receptor agonists | |
| EP3983416C0 (en) | CGRP antagonist compounds | |
| EP3983417C0 (en) | CGRP antagonist compounds | |
| EP3889133A4 (en) | STROGEN RECEPTOR ANTAGONIST | |
| PT3647499T (en) | Concrete structure |